Kvantify Secures €7M ($8.1M USD) Total Funding to Scale Quantum Drug Discovery Platform
Summarize this article with:
Kvantify Secures €7M ($8.1M USD) Total Funding to Scale Quantum Drug Discovery Platform Kvantify has announced the successful second close of its funding round, bringing the total raised to €7 million ($8.1 million USD). The round extension was supported by the European Innovation Council (EIC) Fund and the Denmark-based Delphinus Venture Capital. This capital is earmarked to accelerate the commercialization of Kvantify’s hybrid quantum-classical software stack, specifically targeting the exponential scaling challenges inherent in molecular simulation and drug design. A primary focus of the investment is the expansion of Qrunch, a technology launched in November 2025 designed to execute quantum chemistry workflows on current-generation, noisy quantum hardware. By coupling quantum and classical computing, Qrunch allows researchers to solve quantum mechanical equations that are traditionally too complex for classical supercomputers. The funding will enable Kvantify to broaden its collaborative partnerships with pharmaceutical organizations, moving its “design-to-simulation” roadmap into active industrial workflows to reduce drug development attrition rates and R&D costs. The participation of the EIC Fund and Delphinus Venture Capital—an €80 million fund established in 2025 with backing from Aarhus University and Salling Group—underscores a strategic push to secure European leadership in deep-tech innovation. Kvantify, founded in 2022, is positioning itself as a key intermediary between maturing quantum hardware and the life science industry. By providing a platform that can run realistic chemical simulations on existing hardware, the company seeks to bridge the gap between theoretical quantum advantage and real-world medicinal chemistry. For further details on the funding round and Kvantify’s product roadmap, consult the official announcement here. March 5, 2026 Mohamed Abdel-Kareem2026-03-05T17:16:55-08:00 Leave A Comment Cancel replyComment Type in the text displayed above Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.